Two Female VCs Bet Big On Women’s Health And Sports https://t.co/Keta29Jvul https://t.co/Keta29Jvul ...

[Music] Hi, I'm Swati and I'm going to tell you a story. Story of millions of Indian rural women. I visited villages as a science communicator had you know a lot of energy, enthusiasm and hope to bring more girls into STEM education.But I what I found there uh was pretty disappointing and shocking. There were no girls there. It was anybody's guess why they were not there.Well, girls were there on roads, in houses, in homes, uh playing under the tree, but not in schools. And uh then I realized that there is ...

Core Insights - Progyny, Inc. has announced a partnership with ŌURA to enhance women's health and family building solutions through personalized data and insights [1][4] - The collaboration aims to integrate wearable data from ŌURA into Progyny's care team decision-support process, promoting proactive health management from preconception to menopause [2][4] Company Overview - Progyny is recognized as a global leader in women's health and family building solutions, serving leading employers, health plans, and benefit purchasers [5][6] - The company focuses on comprehensive, inclusive, and intentionally designed solutions that benefit employers, patients, and physicians [5] Partnership Details - The partnership will allow Progyny clients, including employers and health plans, to access ŌURA's smart ring and membership starting in early 2026 [4] - The integration of ŌURA's health metrics will help women track key health indicators, optimize conception attempts, and manage health during menopause [3][4] Health Management Approach - The collaboration emphasizes the importance of daily awareness of health patterns as a foundation for reproductive health management [4] - By utilizing data from the Oura Ring, Progyny aims to facilitate smarter care, earlier interventions, and personalized health journeys for women [4]

Core Insights - WeightWatchers has successfully completed its strategic reorganization, enhancing its financial flexibility and accelerating its transformation with key leadership appointments and product milestones [1][2] - The company is launching an integrated women's health initiative focused on perimenopause and menopause, combining medical, nutritional, lifestyle, and community support [1][6] Leadership Changes - Dr. Kim Boyd has been appointed as Chief Medical Officer to lead the clinical strategy and program innovation, focusing on integrating emerging science into holistic solutions for members [3][4] - Uta Knablein has been appointed as Chief Product Officer to drive product strategy across the expanding weight health platform, bringing over two decades of experience in digital transformation and consumer-centric product development [9] Women's Health Initiative - WeightWatchers will introduce a new program later this year to support women through perimenopause, menopause, and postmenopause, offering tailored nutritional and behavioral strategies along with specialized clinical care [6][7] - The initiative aims to address a significant gap in healthcare for menopause, leveraging the company's existing strengths to deliver sustainable weight loss results [7][8] Board of Directors - A new Board of Directors has been established to guide the company through its next growth phase, including experienced leaders from various sectors such as healthcare and consumer platforms [11][12] - Notable appointments include Mike Mason, former President of Eli Lilly's Diabetes and Obesity business, who will contribute to the company's strategic direction in obesity care [12][13] Company Overview - WeightWatchers is recognized as the global leader in science-backed weight management, with over 60 years of experience and a holistic approach that combines clinical interventions, medications, and community support [16]

The doctor fighting for women's health on Ukraine's front line https://t.co/NsUoLzbN76 ...

June 9, 2025 1 NASDAQ: DARE www.darebioscience.com ©2025 Daré Bioscience | All rights reserved 1 TRANSFORMING WOMEN'S HEALTH We founded Daré with the sole focus of putting women's health first – to boldly address existing gaps and give women the treatment options they want and deserve In Italian, it means "TO GIVE" DARE: In English, it means "TO BE BOLD" 2 2 Forward-Looking Statements; Disclaimers This presentation is for informational purposes only and is not an offer to sell or a solicitation of an offer ...

Core Insights - Progyny, Inc. is expanding its women's health offerings by adding pelvic floor therapy to its services, aiming to improve access and education for women suffering from pelvic floor disorders [1][3] - Approximately one in three women experience pelvic floor issues, with one in five requiring surgery, highlighting the prevalence and impact of these disorders on women's health [2][3] - The company is partnering with Origin and Hinge Health to provide both in-person and virtual pelvic floor therapy, enhancing the accessibility of specialized care [5][6] Summary by Sections Company Initiatives - Progyny is committed to addressing the silent suffering of women by providing expanded care access and educational resources related to pelvic floor disorders [1][3] - The addition of pelvic floor therapy is part of a broader strategy to enhance women's health services from preconception to menopause [1][4] Health Impact - Pelvic floor disorders can lead to significant quality of life issues, including reduced work performance and increased healthcare costs, with urinary incontinence alone costing the healthcare industry $20 billion annually [2][4] - Untreated pelvic health issues are linked to conditions such as endometriosis and infertility, emphasizing the need for timely intervention [2][4] Partnerships and Services - The collaboration with Origin allows Progyny members to access a wide range of pelvic floor physical therapy services, addressing both common and complex pelvic health needs [5][6] - Hinge Health provides digital care plans tailored to individual symptoms, promoting sustainable health habits and symptom relief [6][7] Company Vision and Recognition - Progyny envisions a world where everyone can achieve their family and health goals, supported by a comprehensive network of specialists and innovative solutions [8][9] - The company has received multiple accolades for its leadership and growth in the healthcare sector, including recognition as a TIME100 Most Influential Company and a CNBC Disruptor 50 [10]

Industry Overview & Problem Statement - The silence around perimenopause is a public health crisis with global consequences [4] - Women between 35 and 55 are the forgotten generation in healthcare, with perimenopause impacting them during their prime [5] - By 2030, 1200 million (1.2 billion) women worldwide will be in menopause, and 75% will experience disruptive symptoms [6] - Despite the American Heart Association recognizing menopause as a critical risk factor for heart disease in women in 2020, little action has been taken [7] Economic Impact - The US economy loses $18 million (1.8% billion) annually due to lost workdays related to menopause [9] - One in four women consider leaving their job because of untreated menopause symptoms [8] - Menopause is not just a women's health issue, but also an economic, societal, and leadership issue [14] Healthcare System & Solutions - Menopause is barely a footnote in medical education, leading to misdiagnosis and inadequate care [12] - Women often face dismissive attitudes and inadequate treatment from healthcare providers [3][12] - Medical schools should make menopause education mandatory, business leaders should create supportive workplace policies, and policymakers should advocate for women's health [15]

Core Points - Daré Bioscience, Inc. convened its 2025 annual meeting of stockholders but adjourned it due to a lack of quorum, with plans to reconvene on July 9, 2025 [1][2] - Stockholders who have already submitted proxies or voted do not need to vote again, as their submissions will remain valid [3] - The company emphasizes the importance of voting for stockholders who have not yet participated, providing instructions for online and telephone voting [4] Company Overview - Daré Bioscience is a biopharmaceutical company focused on women's health, aiming to address unmet needs through innovative solutions [8] - The company has developed products such as XACIATO™, a vaginal gel for bacterial vaginosis, and is working on other candidates like Ovaprene® and Sildenafil Cream for various women's health issues [9][10] - Daré's leadership has received recognition for contributions to innovation and advocacy in women's health [11]

Core Insights - Femasys, Inc. has partnered with Carolinas Fertility Institute to offer its FemaSeed intratubal insemination product as a treatment option for infertility in North Carolina [1][2] - The partnership aims to provide a less invasive and cost-effective fertility solution before IVF, enhancing treatment options for patients [2] - FemaSeed is a next-generation artificial insemination solution that significantly improves fertilization rates, achieving over double the pregnancy rates of traditional intrauterine insemination (IUI) in cases of low male sperm count [3][4] Company Overview - Femasys is a biomedical innovator focused on women's health, with a portfolio of patent-protected therapeutic and diagnostic products [4] - The company is actively commercializing its products in the U.S. and international markets, including FemaSeed and FemVue, a diagnostic for fallopian tube assessment [4] - Femasys' FemBloc product, a non-surgical permanent birth control method, is expected to receive full regulatory approval in Europe by mid-2025 [5] Product Details - FemaSeed enhances fertilization by delivering sperm directly to the fallopian tube, offering a safe and cost-effective first-line treatment option [3] - The product is authorized for use in multiple regions, including the U.S., Europe, UK, Canada, and Israel [3] - FemBloc is positioned as a highly cost-effective and safer alternative to traditional surgical sterilization, with commercialization plans in Spain and other European countries [5] Partner Overview - Carolinas Fertility Institute is a leading fertility center in North Carolina, providing a range of reproductive care services [6] - The institute focuses on making fertility care more accessible and effective, aligning with Femasys' mission to offer innovative treatment options [2][6]